Tower Research Capital (TRC)’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4K | Buy |
+7,721
| New | +$15.4K | ﹤0.01% | 3813 |
|
|
2025
Q1 | – | Sell |
-223
| Closed | -$658 | – | 5843 |
|
|
2024
Q4 | $658 | Sell |
223
-2,036
| -90% | -$6.01K | ﹤0.01% | 5209 |
|
|
2024
Q3 | $6.8K | Sell |
2,259
-225
| -9% | -$677 | ﹤0.01% | 4103 |
|
|
2024
Q2 | $8.64K | Sell |
2,484
-960
| -28% | -$3.34K | ﹤0.01% | 4321 |
|
|
2024
Q1 | $18.2K | Sell |
3,444
-5,854
| -63% | -$30.9K | ﹤0.01% | 3081 |
|
|
2023
Q4 | $47.8K | Buy |
+9,298
| New | +$47.8K | ﹤0.01% | 3160 |
|
|
2023
Q2 | – | Sell |
-3,551
| Closed | -$13K | – | 6362 |
|
|
2023
Q1 | $13K | Buy |
3,551
+785
| +28% | +$2.87K | ﹤0.01% | 4018 |
|
|
2022
Q4 | $9K | Buy |
2,766
+223
| +9% | +$726 | ﹤0.01% | 4281 |
|
|
2022
Q3 | $12K | Buy |
2,543
+1,972
| +345% | +$9.31K | ﹤0.01% | 4381 |
|
|
2022
Q2 | $15K | Sell |
571
-614
| -52% | -$16.1K | ﹤0.01% | 4098 |
|
|
2022
Q1 | $44K | Buy |
1,185
+470
| +66% | +$17.5K | ﹤0.01% | 2841 |
|
|
2021
Q4 | $42K | Sell |
715
-224
| -24% | -$13.2K | ﹤0.01% | 2910 |
|
|
2021
Q3 | $78K | Buy |
939
+889
| +1,778% | +$73.8K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $5K | Sell |
50
-1,436
| -97% | -$144K | ﹤0.01% | 4741 |
|
|
2021
Q1 | $95K | Buy |
+1,486
| New | +$95K | ﹤0.01% | 2634 |
|
|
2020
Q4 | – | Sell |
-631
| Closed | -$13K | – | 5431 |
|
|
2020
Q3 | $13K | Buy |
631
+225
| +55% | +$4.64K | ﹤0.01% | 4005 |
|
|
2020
Q2 | $6K | Buy |
+406
| New | +$6K | ﹤0.01% | 4236 |
|
|
2017
Q3 | – | Sell |
-19
| Closed | -$1K | – | 4263 |
|
|
2017
Q2 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 2525 |
|
|
2016
Q3 | – | Sell |
-3
| Closed | – | – | 4511 |
|
|
2016
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 5039 |
|